Lower HER-2/chromosome enumeration probe 17 ratio in cytologic HER-2 fluorescence in situ hybridization for breast cancers: three-dimensional analysis of intranuclear localization of centromere 17 and HER-2 signals (Q80788489)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 April 2008

Language	Label	Description	Also known as
English	Lower HER-2/chromosome enumeration probe 17 ratio in cytologic HER-2 fluorescence in situ hybridization for breast cancers: three-dimensional analysis of intranuclear localization of centromere 17 and HER-2 signals	scientific article published on 01 April 2008

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306351%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Lower HER-2/chromosome enumeration probe 17 ratio in cytologic HER-2 fluorescence in situ hybridization for breast cancers: three-dimensional analysis of intranuclear localization of centromere 17 and HER-2 signals (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306351%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Hitoshi Itoh

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306351%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Yoko Miyajima

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306351%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Shinobu Umemura

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306351%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Robert Y Osamura

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306351%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

1 April 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306351%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306351%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

114

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306351%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306351%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

134-140

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306351%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23367

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23367

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23367

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorescence in situ hybridization for HER-2/neu amplification of breast carcinoma in archival fine needle aspiration biopsy specimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23367

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu gene amplification in breast imprint cytology analyzed by fluorescence in situ hybridization: direct comparison with companion tissue sections.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23367

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu evaluation by fluorescence in situ hybridization on destained cytologic smears from primary and metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23367

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23367

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23367

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis of HER-2/neu gene amplification in breast cancer fine-needle samples

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23367

7 January 2021

based on heuristic

inferred from DOI database lookup

HER2 assessment by immunohistochemical analysis and fluorescence in situ hybridization: comparison of HercepTest and PathVysion commercial assays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23367

7 January 2021

based on heuristic

inferred from DOI database lookup

Her-2/neu gene amplification in low to moderately expressing breast cancers: possible role of chromosome 17/Her-2/neu polysomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23367

7 January 2021

based on heuristic

inferred from DOI database lookup

Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23367

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of HER-2 status and chromosome 17 polysomy in breast carcinomas comparing HercepTest and PathVysion FISH assay.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23367

7 January 2021

based on heuristic

inferred from DOI database lookup

MYC is amplified in BRCA1-associated breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23367

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23367

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306351%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306351%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80788489&oldid=1424774522"